With antibiotics losing their effectiveness, one company is turning to gene editing and bacteriophages—viruses that infect bacteria—to combat infections.
Emily Mullin is a staff writer for WIRED, with a focus on science and technology. Her work has also been featured in publications such as Mother Jones, Canada's National Observer, Teen Vogue, Ars Technica, and Tech News Tube. Emily's articles cover a wide range of topics, from the latest advancements in genetic engineering and CRISPR technology to the impact of psychedelics on mental health and privacy concerns surrounding DNA campaigns for identifying missing persons.